Guorui Properties Ltd (2329) AI Stock Analysis

• Market Cap: €675.55M
• Dividend Yield: N/A
• Average Volume (3M): 9.32M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.36
• Revenue Growth: 4.78%
• EPS Growth: -116.13%
• Country: HK
• Employees: 448
• Sector: Real Estate
• Sector Strength: 52
• Industry: Real Estate - Development
• EPS (TTM): -0.29
• Shares Outstanding: 4,444,418,000
• 10 Day Avg. Volume: 20,807,900
• 30 Day Avg. Volume: 9,315,966
• PEG Ratio: <0.01
• Price to Book (P/B): 0.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 5.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 39 Underperform
• Price Target: HK$0.00 ▼(-100.00%Downside)

The stock is primarily impacted by poor financial performance, including high leverage and cash flow issues, which are the most significant factors. Technical analysis shows overbought conditions, suggesting caution. Valuation concerns further weigh on the stock due to a negative P/E ratio and lack of dividend yield.

Guorui Properties Ltd Business Overview & Revenue Model

Company Description

Glory Health Industry Limited, an investment holding company, engages in the development of real estate properties in the People's Republic of China. The company operates through four segments: Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services. The Property Development segment develops and sells commercial and residential properties. The Primary Land Construction and Development Services segment provides primary land development services, including services for resettlement, and construction of land infrastructure and ancillary public facilities on land owned by the local governments. The Property Investment segment engages in the rental of investment properties. The Property Management and Related Services segment offers property management and related services. It primarily serves individual purchasers for residential properties, as well as various types of corporations and other business entities for commercial properties. The company was formerly known as Guorui Properties Limited and changed its name to Glory Health Industry Limited in July 2022. Glory Health Industry Limited was founded in 1994 and is headquartered in Beijing, China. Glory Health Industry Limited is a subsidiary of Alltogether Land Company Limited.

How the Company Makes Money

Guorui Properties Ltd generates its revenue through several key streams. The primary source of income comes from the sale of residential and commercial properties, which includes the development and sale of high-rise apartments, villas, office buildings, and retail spaces. Additionally, the company earns income from leasing properties, providing a steady stream of rental income from its commercial and retail properties. Guorui Properties also benefits from its property management services, which include maintenance and operational management of its developments, contributing to recurring revenue. Strategic partnerships with local governments and other real estate developers further enhance its project pipeline and revenue potential, allowing the company to tap into new markets and large-scale urban development projects.

Guorui Properties Ltd Financial Statement Overview

Summary

The company's financial performance is weak, with declining revenues, negative profitability, high leverage, and cash flow challenges. The income statement, balance sheet, and cash flow all indicate significant financial difficulties.

Income Statement

The income statement reveals a declining trend in revenue with negative profitability. The gross profit margin has been inconsistent, and the company has been experiencing net losses in recent years. Revenue growth has been negative, and EBIT and EBITDA margins have decreased significantly, highlighting operational challenges.

Balance Sheet

The balance sheet shows a relatively high debt-to-equity ratio, indicating significant leverage, which may pose financial risks. Stockholders’ equity has been decreasing, affecting the equity ratio negatively. The return on equity has been negative due to ongoing net losses, pointing to challenges in generating returns for shareholders.

Cash Flow

Cash flow analysis indicates instability, with a significant decline in free cash flow and operating cash flow over recent periods. The lack of positive free cash flow growth and a negative operating cash flow to net income ratio highlight cash flow management issues, potentially impacting liquidity.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.71B	2.51B	3.90B	9.90B	5.77B
Gross Profit	555.56M	-50.28M	113.52M	1.25B	980.32M
EBITDA	295.14M	-145.86M	-325.93M	581.55M	1.09B
Net Income	-1.24B	-563.97M	-912.78M	228.33M	98.74M
Balance Sheet
Total Assets	57.20B	56.35B	57.39B	61.07B	67.52B
Cash, Cash Equivalents and Short-Term Investments	158.10M	152.22M	189.51M	556.87M	1.65B
Total Debt	22.79B	22.18B	21.25B	20.95B	23.52B
Total Liabilities	44.83B	42.57B	43.01B	45.64B	52.41B
Stockholders Equity	9.93B	11.17B	11.73B	12.71B	12.49B
Cash Flow
Free Cash Flow	678.26M	452.11M	413.47M	4.07B	4.67B
Operating Cash Flow	679.53M	512.92M	606.31M	4.35B	4.94B
Investing Cash Flow	146.72M	58.95M	-305.41M	184.15M	-2.78B
Financing Cash Flow	-830.50M	-627.40M	-630.90M	-5.65B	-1.11B

Guorui Properties Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.16
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2329, the sentiment is Positive. The current price of 0.16 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.05, and above the 200-day MA of 0.09, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 90.72 is Negative, neither overbought nor oversold. The STOCH value of 80.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2329.

Guorui Properties Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	£989.01M	11.77	-0.08%	5.05%	10.32%	31.28%
0865	54 Neutral	HK$262.71M	30.00	-5.30%	―	-72.42%	-1037.50%
2329	39 Underperform	€675.55M	―	-11.65%	―	4.78%	-116.13%
1ZZ		€18.90M	―		―	―	―
3ZH		€39.47M	―	-42.12%	―	―	―
YC2		€19.00M	―	-27.47%	―	―	―

Guorui Properties Ltd Corporate Events

Glory Health Industry Limited Appoints New Independent Directors

Glory Health Industry Limited, incorporated in the Cayman Islands, has announced the appointment of three independent non-executive directors: Ms. Chen Jinrong, Mr. Deng Zhidong, and Mr. Yuan Hao. The company emphasizes the independence of these directors, confirming they have no financial or other interests in the company’s business or connections with core connected persons. This move is expected to strengthen the company’s governance and ensure compliance with relevant listing rules, potentially enhancing stakeholder confidence.

Glory Health Industry Limited Passes All Resolutions at Annual General Meeting

Glory Health Industry Limited, a company incorporated in the Cayman Islands, held its annual general meeting on June 30, 2025, where all proposed resolutions were passed by a majority vote. Key resolutions included the adoption of the company’s audited financial statements for 2024, the re-election of certain directors, the reappointment of WM CPA Limited as auditors, and the granting of mandates to issue and repurchase shares. The meeting’s outcomes reflect strong shareholder support for the company’s current management and strategic direction.

Glory Health Industry Addresses Auditor’s Disclaimer with Strategic Measures

Glory Health Industry Limited has announced updates regarding a disclaimer of opinion issued by its auditors concerning the company’s consolidated financial statements for the year ended December 31, 2024. The disclaimer highlights material uncertainties that may impact the company’s ability to continue as a going concern. In response, the company has taken measures to address these concerns, including extending borrowings, negotiating asset sales, and applying for government approval for land returns. The management aims to complete debt restructuring and asset disposal by the second half of 2025, with regular updates to be provided every three months.

Glory Health Industry Limited Announces Board Composition and Committee Structure

Glory Health Industry Limited, incorporated in the Cayman Islands, has announced the composition of its board of directors and the establishment of four key committees. The board includes both executive and independent non-executive directors, with Zhang Zhangsun serving as Chairman. This announcement outlines the roles and functions of each board member, highlighting the company’s governance structure and commitment to effective management.

Glory Health Industry Faces Compliance Challenge After Director’s Resignation

Glory Health Industry Limited has announced the resignation of Mr. Yuan Hao from his roles as an independent non-executive director, chairman of the Internal Control Committee, and a member of the Audit Committee, effective June 10, 2025, due to work arrangements. This resignation impacts the company’s compliance with certain listing rules, as it reduces the number of independent non-executive directors and Audit Committee members below the required minimum. The company is actively seeking a suitable candidate to fill the vacancy within three months to meet regulatory requirements.

Glory Health Industry Limited Announces 2025 Annual General Meeting

Glory Health Industry Limited has announced its upcoming annual general meeting scheduled for June 30, 2025, in Beijing. The meeting will address several key resolutions, including the adoption of audited financial statements for 2024, the re-election of directors, and the re-appointment of auditors. Additionally, the company seeks approval to allot and issue shares, which could impact its capital structure and shareholder value.

Glory Health Industry Extends Loan Maturity Dates

Glory Health Industry Limited announced an extension of the maturity dates for certain loans held by its subsidiary, Glory Xingye (Beijing) Investment Co., Ltd., with the Bank of Tianjin Co., Ltd. The loans, totaling RMB1,314.09 million, will now mature on October 7, 2027, instead of April 8, 2025. This extension reflects the company’s strategic financial management and may impact its financial stability and stakeholder confidence.